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Dietary flavonoids may protect against sunburn inflammation in skin. Preliminary reports using less complete analysis suggest that certain catechins and
their metabolites are found in skin biopsies and blister fluid after consumption of green tea; however, it is not known if they are affected by solar-simulated
ultraviolet radiation (UVR) or whether conjugated forms, with consequently altered bioactivity, are present. The present study tested the hypothesis that UVR
affects the catechin levels in the skin of healthy volunteers after consumption of green tea and how catechins in the plasma are related to their presence in skin
tissue samples. In an open oral intervention study, 11 subjects consumed green tea and vitamin C supplements daily for 3 months. Presupplementation and
postsupplementation plasma samples, suction blister fluid and skin biopsies were collected; the latter two samples were collected both before and after UVR. A
sensitive high-performance liquid chromatography/mass spectrometric assay was used to measure the intact catechin metabolites, conjugates and free forms.
Seven green tea catechins and their corresponding metabolites were identified postsupplementation in skin biopsies, 20 in blister fluid and 26 in plasma, with 15
green tea catechin metabolites present in both blister fluid and plasma. The valerolactone, O-methyl-M4-O-sulfate, a gut microbiota metabolite of catechins, was
significantly increased 1.6-fold by UVR in blister fluid samples. In conclusion, there were some common catechin metabolites in the plasma and blister fluid, and
the concentration was always higher in plasma. The results suggest that green tea catechins and metabolites are bioavailable in skin and provide a novel link
between catechin metabolites derived from the skin and gut microbiota.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Green tea catechin conjugates; Polyphenols; Bioavailability; Ultraviolet radiation; Skin1. Introduction
Daily consumption of green tea is associated with positive effects
on human health [1–5]. Epidemiological studies have correlated greenAbbreviations: AA, ascorbic acid; BMI, body mass index; C, catechin; Cmax,
peak plasma concentration; EC, epicatechin; EG, ethyl gallate; EGC, epigallo-
catechin; ECG, epicatechin gallate; EGCG, epigallocatechin gallate; IS, internal
standard; LC-MS/MS, liquid chromatography tandem mass spectrometry;
LOQ, limit of quantiﬁcation; Me, methyl; MED, minimal erythema dose; SE,
standard error; Tmax, time to reach maximum plasma concentration; UVR,
ultraviolet radiation
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[6,7]. In vitro and in vivo studies also support the concept of protection
against UVR-induced inﬂammation in skin by green tea consumption
[8–14].
The skin is a metabolically active organ that acts as a barrier to
protect the internal organs from the external environment, such as
ultraviolet radiation (UVR) [15]. UVA and UVB penetrate the ozone
layer, come into contact with the skin and initiate effects inside the
cell, including changes in gene expression, generation of cytokines and
proinﬂammatory lipid mediators and generation of reactive oxygen
species [16–20]. Acute UVR exposure causes inﬂammation (sunburn)
and photosensitivity, while repeated exposure leads to photoaging
and carcinogenesis [21,22]. Increased levels of sunlight exposure are a
considerable health concern, with, for example, a signiﬁcant increase
in the malignant melanoma incidence observed between 1975 and
2010 in the United Kingdom [23]. The current use of topical sunscreen
for UVR protection has limitations, including poor application and
infrequent use outside of the holiday season [20]. Improving
protection against UVR, possibly through a dietary source, may reduce
the incidence of carcinogenesis.er the CC BY license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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including catechin (C), epicatechin (EC), epigallocatechin (EGC),
epicatechin gallate (ECG) and epigallocatechin gallate (EGCG).
Previous bioavailability studies have identiﬁed that, following con-
sumption, green tea catechins undergo phase II metabolism, and
pharmacokinetic studies have shown the presence of the conjugated
forms in plasma,with EGCG andECGpartially present as unconjugated
forms [24,25]. Recent bioavailability studies have focused mainly on
the conjugated forms of catechin metabolites in urine and plasma
samples [26–28]. The presence of green tea catechins in various tissues
has also been identiﬁed in vivo [29,30], including our previous pilot
study [31]; however, the conjugated forms have not been assessed
previously. This is important since the metabolites and conjugates of
catechins have very different biological activities and transport
properties compared to the parent compounds.
In our previous pilot study [31], we made a preliminary
identiﬁcation of 8 green tea catechins (presence or absence following
enzyme deconjugation assays) in skin biopsy samples, after the daily
consumption of green tea catechin supplements and vitamin C (at the
equivalent of 2 cups of green tea) for 3 months. The present study
utilized an improved method [32], which is applicable for monitoring
both the free and conjugated forms of green tea catechins in biological
samples, particularly for those containing endogenous β-glucuroni-
dase and sulfatase activities, following daily green tea and vitamin C
supplement consumption (at the equivalent of 5 cups of green tea).
We used this method to evaluate their oral bioavailability in skin by
obtaining and assessing skin biopsies and blister ﬂuid (pre-UVR and
post-UVR), plasma and urine to understand whether the presence of
catechins in tissues can be related to plasma.
2. Materials and methods
2.1. Study design
A total of 12 subjects were recruited between September 2011 and January 2012 for
the 3-month open oral intervention study conducted in the Photobiology Unit, Centre
for Dermatology Research, Salford Royal NHS Foundation Hospital (Manchester, United
Kingdom). Inclusion criteria were as follows: healthy, aged 18–65 years, sun-reactive
skin type I/II and body mass index (BMI) b35 kg/m2. Exclusion criteria were as follows:
history of skin cancer, photosensitivity disorder or atopy, sunbathing or use of sunbeds
in the past 3 months, taking photoactive medication or nutritional supplements and
drinking N2 cups of tea per day.
Subjects consumed supplements daily that were the equivalent of 5 cups of green
tea. Green tea supplements were gelatine capsules each containing 450 mg green tea
(180 mg green tea catechins) and a further set of capsules each containing 25 mg
vitamin C. Subjects were administered 3 green tea and 2 vitamin C capsules twice daily
(to consume with breakfast and the evening meal; total 1080 mg green tea catechins
and 100 mg vitamin C daily) for 12 weeks. Vitamin C was added to stabilize the green
tea extract in the gut lumen [33] and has no impact on UVR erythema [34]. During the
course of the study, four sample types were collected; plasma, skin blister ﬂuid, skinTable 1
Green tea catechin and vitamin C supplementation and sample collection protocol.
Time point Protocol
Day−2 24 h urine collection (baseline)
Assess MED and apply 3× MED for UVR exposed samples
Day−1 Suction blister (1× no UVR, 1× 3× MED UVR)
Punch biopsy (1× no UVR, 1× 3× MED UVR)
Day 0 (supplementation
period commenced)
24 h urine collection (postingestion)
Plasma pharmacokinetics
(preingestion: 0 h)
(postingestion: 0.5, 1, 1.5, 2, 4, 6 h)
24 h urine collection
Week 6 24 h urine collection
Week 12, day−1 Apply 3× MED UVR
Week 12 Suction blister (1× no UVR, 1× 3× MED UVR; initiated 1 h
and samples obtained ~3 h postingestion)
Punch biopsy (1× no UVR, 1× 3× MED UVR; samples
obtained 3 h postingestion)
Plasma collection (3 h postingestion)biopsies and urine (Table 1). Urine was collected over 24 h at four points during the
intervention: baseline (day −1, presupplementation), day 0 (postsupplementation),
week 6 and week 12. Plasma was collected for the pharmacokinetic analysis on the ﬁrst
day of supplementation (day 0) and again at 3 h postconsumption during week 12. All
samples were stored at−80°C prior to analysis.
2.2. Ethics
Ethics approval was received from the North Manchester Research Ethics
Committee (reference 08/H1006/79; clinicaltrials.gov identiﬁer: NCT01032031). All
subjects gave written informed consent and the study conformed to the Declaration of
Helsinki principles.
2.3. UVR exposure and skin sampling procedures
Solar-simulated radiation (Newport Spectra Physics Ltd, Didcot, United Kingdom),
mimicking theUVR emission of sunlight (290–400 nm; 95%UVA and 5%UVB),was used
for all UVR exposures. The light source was located 10 cm away from the skin and a
radiometer was used to calibrate the source and conﬁrm consistency of application. To
determine the sunburn threshold, skin was irradiated with a geometric series of 10
doses of UVR. After 24 h, the lowest dose that produced a visually discernible erythema
was deﬁned as the minimal erythema dose (MED). This determined the UVR dose that
was subsequently used in the study; a dose that was 3 times the individual’s MED was
applied to buttock skin 24 h prior to skin tissue and blister ﬂuid sampling.
Skin was sampled at presupplementation baseline and 12 weeks postsupplemen-
tation, with UVR exposures performed on one buttock and the other buttock providing
control unexposed samples. Suction blister and punch biopsy procedures were
performed as described previously [18]. Skin biopsies (5 mm punch) were snap frozen
in liquid nitrogen. Blister ﬂuid was removed with a needle and combined with 25 μl
NaH2PO4 [0.4 mol/L with 200 g/L ascorbic acid (AA) and 1 g/L EDTA, pH 3.6] then snap
frozen in liquid nitrogen. All samples were stored at−80°C prior to analysis.
2.4. Pharmacokinetics
Pharmacokinetic analysis of green tea catechin uptake and metabolism was
performed as follows (Table 1). Subjects were instructed to fast from midnight. The
following morning, an 18-G cannula was inserted into the right antecubital fossa. A
baseline blood sample was taken and then subjects consumed a standard breakfast
consisting of ﬂavonoid-free cereal (cornﬂakes) with semi-skimmed milk, one slice of
white toast with butter and a glass of water. A single oral dose of green tea catechins
(540 mg total green tea catechins) with 50 mg vitamin C was administered 5 min after
consumption of breakfast. Further blood samples were taken at 0.5, 1, 1.5, 2, 3, 4 and 6 h
postsupplement consumption with subjects consuming a standard lunch of a cheese
and chicken sandwich onwhite bread and a slice of ﬂavonoid-free cake following the 4-h
sample. Plasma was separated by centrifugation, stored at −80°C and analyzed as
described below.
2.5. Materials
EC, EGC, ECG, EGCG, C and taxifolin were purchased from Extrasynthése (Genay,
France). Ethyl gallate (EG) and 3-methyl gallic acid were obtained from Apin Chemicals
Ltd (Oxfordshire, United Kingdom), hippuric acid, benzoic acid and 3-hydroxybenzoic
acid were purchased from Fluka (Dorset, United Kingdom); AAwas from Sigma Aldrich
(Dorset, United Kingdom) and syringic acid and gallic acid were purchased from Alfa
Aesar (Lancashire, United Kingdom). All standards were high-performance liquid
chromatography grade (N90%). EC-O-sulfate and EGC-O-glucuronide were synthesized
using the method by Wong et al. [35]. A Millipore Q water purifying system (Millipore,
Hertfordshire, United Kingdom) provided ultrapure water (≥18.2 MΩ cm at 25°C) for
liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. Standard
curves were generated for aglycones (free forms) by spiking standards into blank,
presupplementation plasma and blister samples (R2N0.97). Recoveries were calculated
by spiking known amounts of standards into blank, presupplement plasma, blister and
biopsy samples (postcryopulverization) and relating the peak area from the spiked
sample to the peak area from the direct analysis of an equivalent volume by LC-MS/MS.
2.6. Sample analysis
2.6.1. Urine analysis for compliance
Urine was excreted into HCl-washed ﬂasks containing AA (~1 g/L) and stored at−80°C
prior to analysis. Compliance to the studywas tested throughmonitoring the presence of EC-
O-sulfate and EGC-O-glucuronide in the urine during the trial at the four time points and by
counting residual supplements (Table 1). The urine samples were analyzed by LC-MS/MS
according to our previous method [32].
2.6.2. Plasma analysis
Plasma samples were removed from−80°C storage and thawed on ice. The whole
procedure was performed on ice. The samples were gently vortexed before 380 μl
(technical duplicates for each biological sample) was removed and placed in a 2 ml
Eppendorf with 20 μl AA (22.5 mmol/L in water; ﬁnal concentration of 1 mmol/L) and
Table 2
Recovery of green tea catechins and relatedmetabolites in the plasma and skin samples.
Recovery
Compound Plasma Blister ﬂuid Skin biopsy
% % %
EC 107±14 90±2 102±27
EGC 103±3 75±8 105±6
EC-O-sulfate 117±2 86±2 108±15
EGC-O-glucuronide 97±2 32±5 62±13
EG 93±1 104±13 96±4
Recovery data are expressed as percentages of corresponding standards (mean±SE).
Recoveries were performed in technical triplicate at a minimum of three concentra-
tions. EC, epicatechin; EG, ethyl gallate; EGC, epigallocatechin.
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hexane (Sigma Aldrich, Dorset, United Kingdom) was added drop-wise to the Eppendorf
tube. The samples were vortexed for 1 min and centrifuged at 17,000g (4°C) for 10 min.
The top fat layer was removed to waste and the sample was placed back on ice; 500 μl of
ice-cold ethyl acetate was added and the procedure continued as for urine. The only
changes in relation to the urine protocol were the addition of 1.5 ml acetonitrile to the
sample remaining after the ethyl acetate extraction (therefore the preweighed tubewas a
2-ml Eppendorf) and the injection of 10 μl for LC-MS/MS analysis. Prepared sampleswere
stored at−20°C and defrosted on ice before LC-MS/MS analysis.
2.6.3. Blister fluid analysis
Blister samples were removed from −80°C storage and thawed on ice. The initial
volumes were recorded (101±44 μl). The whole procedure was performed on ice and
immediately analyzed by LC-MS/MS. Two technical replicates were performed for each
biological sample when there was N80 μl initially. The samples were gently vortexed
and brieﬂy spun down. Blister ﬂuid (40 μl) was added to an Eppendorf, alongwith 10 μl
of 0.4 mol/L NaH2PO4 solution (containing 200 g/L AA, 1 g/L EDTA and 0.04 μg/10 μl
EG). Ice-cold ethyl acetate (300 μl) was added and the sample followed the same
procedure as for urine; however, 160 μl acetonitrile was used, the sample was only
centrifuged at 17,000g (4°C) for 5 min and the samples were reconstituted back to 20 μl
using water before vortexing for 1 min after reweighing the Eppendorf tubes. Of the
sample, 18 μl was collected and added to the corresponding dried-down ethyl acetate
tube with 2 μl taxifolin (20 μg/ml in 50% acetonitrile and 1% AA). The samples were
sonicated for 5 min and 9.5 μl was added to twowells on a coveredmicrowell plate and
5 μl of the sample was injected for LC-MS/MS analysis.
2.6.4. Biopsy analysis
Skin biopsies were removed from −80°C storage and the initial weights were
recorded using preweighed 2-ml Eppendorf tubes. The procedure was conducted on ice
prior to immediate analysis by LC-MS/MS. The biopsies were held with sterilized
tweezers over a waste beaker and ﬂushed with ice-cold hexane to remove any blood
and lipid present on the outer layer. Afterwashingwith hexane, a stainless-steel rod and
basewere placed into a vat of liquid nitrogen for approximately 1 min until effervescing
ceased. This was removed and, using tweezers, a biopsywas placed into the vat of liquid
nitrogen until effervescing stopped. The biopsywas removed, placed in between the rod
and base and pulverized with a hammer (cryopulverization). The sample was
immediately placed back into the 2-ml Eppendorf tube using a scalpel and tweezers
and was stored at−80°C until required. In between each biopsy procedure, the scalpel
and tweezers were resterilized using 70% ethanol and hot water.
Prior to LC-MS/MS analysis, each pulverized sample was further homogenized
using a microhomogenizer (Ultra Turrax, IKA T10 Basic; IKA Ltd, Cheshire, United
Kingdom). To the 2-ml Eppendorf tube containing the cryopulverized biopsy sample,
100 μl ice-cold chloroform (with 0.1 g/L butylated hydroxytoluene; Fisher Scientiﬁc
Ltd, Leicestershire, United Kingdom) and 100 μl ice-cold sodium dithionite (0.3 mol/L,
with 0.08 μg EG; Sigma Aldrich, Dorset, United Kingdom) were added. The biopsy was
homogenized by shearing of the samples on dry ice, to reduce the heat produced by the
sheering process. After homogenization (for approximately 5 min), the sample was
maintained on dry ice for 2 min before centrifuging for 2 min at 17,000g (4°C). The top
aqueous layer was removed to a new Eppendorf tube and 100 μl of 0.3 mol/L sodium
dithionite (not containing EG) was added to the biopsy sample, which was then
vortexed for 1 min. The sample was placed on dry ice for 2 min and centrifuged again
with the resulting top aqueous layer being combined with the previous.
Ice-cold ethyl acetate (500 μl) was added and the sample followed the same
procedure as for urine; however, 600 μl acetonitrile was used. The samples were
reconstituted to 40 μl withwater and 36 μlwas added to the corresponding dried-down
ethyl acetate Eppendorf, alongside 4 μl taxifolin (20 μg/ml in 50% acetonitrile and 1%
AA). The samples were sonicated for 5 min and 18 μl was added to two separate wells
on a covered microwell plate prior to LC-MS/MS analysis (injection volume: 10 μl).
2.6.5. LC-MS/MS analysis
Reverse-phase LC-MS/MS was performed as previously described [32], using an
Agilent 1200 SL system (Agilent Technologies, Dorset, United Kingdom) connected to a
6410 triple quadrupole LC-MS/MS with electrospray ionization on the negative mode,
with multiple reaction monitoring (Agilent Technologies, Santa Clara, CA, USA) with a
Kinetex C18 column (2.6 μm, 150×2.1 mm; Phenomenex, Cheshire, United Kingdom).
As green tea catechin conjugates (sulfate and glucuronide) are not commercially
available, catechin conjugates were analyzed using peak area, and free forms were
analyzed relative to known standards, relative to the internal standard EG (2 μg/ml). A
total of 55 metabolites (green tea catechins, metabolites and conjugated forms) were
investigated, and the MS transitions are as previously reported [32].
2.7. Statistical analysis
Differences in GTC and metabolite concentrations presupplementation and
postsupplementation from UVR-exposed and UVR-unexposed skin were compared
using the Friedman test with post hoc Wilcoxon signed-rank tests or analysis of
variance. Pb.05 was considered to indicate a statistically signiﬁcant difference. Data are
presented as mean±standard error (SE) for n=11 subjects.3. Results
3.1. Subjects
One subject was excluded from analysis as the subject could not
provide blood samples. Thus, 11 subjects (six males, ﬁve females;
median age, 21 years; range, 18–58 years) completed the study and
no side effects were reported. BMI was median (range) 24.4 (18.2–
33.8) at baseline, 24.9 (18.2–34.5) at 6 weeks and 24.3 (17.8–34.8) at
12 weeks, with no signiﬁcant change.3.2. Recovery of the metabolites and conjugates from skin and plasma
samples
EC, EGC, EC-O-sulfate and EGC-O-glucuronide recoveries and the
limit of quantiﬁcation (LOQ) for the different sample types are shown
in Tables 2 and 3. The coefﬁcient of variance for the recovery of spiked
catechins and conjugates fromplasma, blister and skin biopsy samples
ranged from 0.01 to 0.1, 0.03 to 0.2 and 0.1 to 0.2, respectively,
indicating that sample processing resulted in suitable reproducibility.
The majority of the standards were recovered between 90% and 100%
in the biological samples, except for EGC-O-glucuronide in the blister
and biopsy samples. The exact chemical substitution positions of the
conjugatemoieties (methyl ester, sulfate ester and glucuronic acid) of
the green tea catechin metabolites are unknown in the results
presented and will therefore be referred to as O-methyl-catechin-O-
glucuronide or O-methyl-catechin-O-sulfate.3.3. Plasma pharmacokinetics
The green tea catechinmetabolites were detected after 1 h, except
for EC-O-glucuronide, which was ﬁrst detected 1.5 h postsupplement
consumption. Tmax values were calculated for the individual metab-
olites and ranged between 3 and 4 h. Cmax values were calculated as
peak area relative to the internal standard and ranged between 0.03
and 0.2. The pharmacokinetics for the 11 subjects were collated and
presented as the mean±SE and also as individual pharmacokinetic
curves. Example pharmacokinetics for O-methyl-O-EC-O-sulfate, EC-
O-sulfate and EGC-O-glucuronide are displayed in Fig. 1.
There were 26 green tea catechin metabolites present in the
plasma samples after 3 months supplementation, obtained 3 h
postconsumption of the ﬁnal dose of the supplement (Table 4). In
comparison to the 3-h postconsumption sample on day 0 of
supplementation, there were 7 additional metabolites present in the
3-month samples, including the gut microbiota metabolites, valer-
olactones (M4-O-sulfate, M4-O-glucuronide and M6/M6′-O-glucuro-
nide) and a signiﬁcant increase in EC-O-sulfate andM6/M6′-O-sulfate.
Table 3
LOQ for the free-form green tea catechin metabolites (related to sulfate or glucuronide
forms) for each biological sample.
LOQ
Compound Plasma Blister ﬂuid Skin tissue biopsy
pmol/L pmol/L pmol/mg tissue
EC 2 20 NA
3′-O-Me EC 1 20 NA
4′-O-Me EC 0.1 NA 1
EGC 0.2 10 NA
3′-O-Me EGC 1 NA NA
4′-O-Me EGC 0.6 230 NA
ECG 0.1 NA NA
EGCG 0.1 NA NA
Gallic acid 40 110 NA
3-O-Me gallic acid 2 10 10
Quercetin 20 60 30
Kaempferol 110 NA NA
M6 3 30 9
Syringic acid 20 40 NA
3-Hydroxybenzoic acid 5 30 NA
Benzoic acid 50 590 NA
Hippuric acid 0.4 40 NA
EC, epicatechin; ECG, epicatechin gallate; EGC, epigallocatechin; EGCG, epigallocatechin
gallate; Me, methyl; NA, not assessed using free-form standards, as the free-form or
associated sulfate or glucuronide form was not identiﬁed in a sample.
Fig. 1. Average and individual pharmacokinetics for green tea catechinmetabolites in the plasma
of supplementation). The pharmacokinetics are for O-Me-O-EC-O-sulfate, EC-O-sulfate and EG
mean±SE; n=11 subjects). EC, epicatechin; EG, ethyl gallate; EGC, epigallocatechin; IS, intern
206 K.A. Clarke et al. / Journal of Nutritional Biochemistry 27 (2016) 203–2103.4. Blister fluid
We identiﬁed 20 green tea catechinmetabolites in blister ﬂuid, with
few detected in baseline samples and themajority identiﬁed post green
tea supplementation for 3 months (Table 5). The most prominent
conjugated forms of EC and EGC, identiﬁed as the largest peak areas
relative to the internal standard, were EC-O-sulfate, O-methyl-EC-O-
sulfate andO-methyl-EGC-O-sulfate. For the valerolactones,M6/M6′-O-
sulfate andO-methyl-M4-O-sulfate had the highest corresponding peak
areas relative to the internal standard. O-Methyl-M4-O-sulfate was the
only metabolite that was signiﬁcantly increased in the postsupplemen-
tation UVR sample compared to the no-UVR sample.3.5. Skin biopsy
Metabolites identiﬁed in the skin biopsy samples postsupplemen-
tation were O-methyl-EC-O-sulfate, gallic acid-O-glucuronide, O-
methyl-gallic acid-O-sulfate, O-methyl-gallic acid-O-glucuronide,
quercetin and M6 (Table 6). M6 was present in each sample from
one volunteer and was the only metabolite identiﬁed in the
presupplementation samples. No signiﬁcant difference was found
between the green tea catechin conjugates andmetabolites present in
the pre-UVR and post-UVR skin biopsies.of each volunteer postconsumption of green tea supplementation on day 0 (theﬁrst day
C-O-glucuronide (assessed as peak area, relative to the internal standard, 2 μg/ml EG;
al standard; Me, methyl.
Table 4
Changes in the concentration of green tea catechin metabolites present in plasma 3 h
postingestion of a green tea supplement on the ﬁrst day (day 0) and after 3 months of
supplementation.
Compound Ingestion of green tea supplement
3 h, day 0 3 h, 3 months
Conjugated form Peak area ratio Peak area ratio
EC-O-sulfate 14±2 (10) 23±4 ⁎ (11)
EC-O-glucuronide 4±1 (7) 5±1 (9)
O-Me-EC-O-sulfate 13±2 (10) 21±4 ⁎ (11)
EGC-O-sulfate 4±1 (3) 3.3±0.7 (2)
EGC-O-glucuronide 5.9±0.7 (9) 8±2 (10)
O-Me-EGC-O-sulfate 10±2 (9) 12±2 (11)
O-Me-EGC-O-glucuronide 1.8±0.5 (3) 1.9±0.4 (6)
ECG-O-sulfate ND 3 (1)
Gallic acid-O-sulfate ND 4±1 (2)
O-Me-gallic acid-O-sulfate 40±7 (11) 50±9 (11)
Quercetin-O-sulfate ND 2.5±0.4 (3)
Kaempferol-O-glucuronide ND 3 (1)
M4-O-sulfate ND 10±2 (9)
M4-O-glucuronide ND 2.0±0.7 (5)
O-Me-M4-O-sulfate 1 (1) 38±8 (9)
M6/M6′-O-sulfate 10±4 (8) 60±20 ⁎ (11)
M6/M6′-O-glucuronide ND 5±2 (7)
O-Me-M6/M6′-O-sulfate 4±2 (3) 5.6±0.4 (2)
Benzoic acid-O-sulfate 19±6 (11) 14±3 (10)
3-Hydroxybenzoic acid-O-sulfate 1 (1) 6±3 (3)
Syringic acid-O-sulfate 7±6 (4) 3±1 (5)
Free form μM μM
EGC 0.2 (1) 0.24±0.01 (2)
ECG 0.08 (1) 0.25±0.04 (2)
EGCG 0.10±0.02 (4) 0.3±0.1 (4)
3-Hydroxybenzoic acid 4±1 (5) 9±3 (7)
Hippuric acid 1.4±0.4 (10) 1.6±0.2 (11)
Data for the conjugated forms are the average peak area ratio (×10−2) of the compound
relative to the internal standard, EG (2 μg/ml). Data are presented asmean±SE, and the
data in brackets are the number of subjects themetabolitewas identiﬁed in.Whenno SE
is presented, themetabolitewas only detected in one volunteer. Sampleswere analyzed
in biological duplicate and technical triplicate. EC, epicatechin; ECG, epicatechin gallate;
EGC, epigallocatechin; EG, ethyl gallate; EGCG, epigallocatechin gallate; Me, methyl;
ND, not detected.
⁎ Pb.05 compared to day 0 (analysis of variance).
Table 5
Green tea catechin metabolites in blister ﬂuid presupplementation and postsupplementation,
Compound Amount/blister ﬂuid collected
Pre, No UVR Pre
Conjugated form Peak area ratio/μl Pea
EC-O-sulfate ND ND
EC-O-glucuronide ND ND
O-Me-EC-O-sulfate ND ND
EGC-O-glucuronide ND ND
O-Me-EGC-O-sulfate ND ND
O-Me-EGC-O-glucuronide ND ND
Gallic acid-O-glucuronide 1±1 (2) 12
O-Me-gallic acid-O-sulfate 57±37 (11) 90±
M4-O-sulfate ND ND
M4-O-glucuronide ND ND
O-Me-M4-O-sulfate ND ND
M6/M6′-O-sulfate 7±4 (3) 15±
M6/M6′-O-glucuronide ND ND
Benzoic acid-O-sulfate ND ND
Syringic acid-O-sulfate ND 2 (
Syringic acid-O-glucuronide ND 2 (
3-Hydroxybenzoic acid-O-sulfate ND ND
Free form pmol/μl pm
EGCG 20 (1) 14
Hippuric acid 340±380 (11) 670
Benzoic acid 10,550 (1) 30,
Data are the average peak area ratio relative to the internal standard (EG; 2 μg/ml) ×10−6 in to
12 weeks supplementation andwith or without UVR irradiation. Samples were analyzed in bio
of subjects in which the metabolite was identiﬁed. EC, epicatechin; EGC, epigallocatechin; EG
⁎ Pb.05 compared to post no UVR (two-tailed Wilcoxon signed-rank test).
Table 6
Green tea catechin metabolites in skin biopsies presupplementation and
postsupplementation, with or without UVR exposure.
Compound Amount/biopsy weight
Pre, No UVR Pre, UVR Post, No UVR Post, UVR
Conjugated form Peak area
ratio/mg
Peak area
ratio/mg
Peak area
ratio/mg
Peak area
ratio/mg
O-Me-EC-O-sulfate ND ND 20 (1) ND
Gallic acid-O-glucuronide ND ND 8 (1) 9 (1)
O-Me-gallic acid-O-sulfate ND ND ND 6 (1)
O-Me-gallic acid-O-glucuronide ND ND ND 14 (1)
M6/M6′-O-sulfate ND ND 9±5 (2) 8±2 (3)
Free form pmol/mg pmol/mg pmol/mg pmol/mg
Quercetin ND ND 120 (1) ND
M6 240 (1) 370 (1) 230 (1) 80 (1)
Data are the average peak area ratio relative to internal standard (EG; 2 μg/ml) ×10−7,
standardized to the initial weight of the biopsy. Samples were analyzed presupple-
mentation and postsupplementation and with or without UVR irradiation. Samples
were analyzed in technical duplicate; mean±SE; data in brackets are the number of
subjects in which the metabolite was identiﬁed. EC, epicatechin; EG, ethyl gallate; Me,
methyl; ND, not detected.
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There were 15 green tea catechin metabolites (both free and
conjugated forms) present in at least two of the biological samples,
whichwere EC-O-sulfate,O-methyl-EC-O-sulfate, EGC-O-glucuronide,
O-methyl-EGC-O-sulfate, EGCG, O-methyl-gallic acid-O-sulfate, M4-
O-sulfate, M4-O-glucuronide, O-methyl-M4-O-sulfate, M6/M6′-O-
sulfate, M6/M6′-O-glucuronide, benzoic acid-O-sulfate, 3-hydroxybenzoic
acid-O-sulfate and hippuric acid (Fig. 2). Themajority of themetabolites
thatwere present in blister ﬂuid were also present in the plasma. There
were only two metabolites that were identiﬁed in all plasma, blister
ﬂuid and biopsy samples: O-methyl-gallic acid-O-sulfate (in six
subjects) and M6/M6′-O-sulfate (in three subjects).with or without UVR exposure.
, UVR Post, No
UVR
Post, UVR
k area ratio/μl Peak area ratio/μl Peak area ratio/μl
5±3 (10) 9±5 (8)
ND 3±2 (3)
4±2 (8) 5±3 (10)
2±2 (2) 3.3±0.2 (2)
3±2 (6) 2±2 (7)
1 (1) 2 (1)
(1) ND ND
73 (11) 46±28 (11) 55±38 (11)
2±1 (4) 5±3 (4)
0.7±0.4 (2) 4 (1)
9±6 (6) 14±8 ⁎ (7)
16 (2) 46±47 (10) 78±88 (9)
3±3 (4) 6±5 (4)
2 (1) 4±4 (3)
1) ND ND
1) ND ND
8 (1) 8±6 (3)
ol/μl pmol/μl pmol/μl
(1) 9 (1) ND
±800 (11) 230±150 (11) 350±330 (11)
570 (1) ND ND
tal blister ﬂuid extracted for the conjugated forms. Samples were analyzed pre and post
logical duplicate and technical duplicate; mean±SE. The data in brackets are the number
, ethyl gallate; EGCG, epigallocatechin gallate; ND, not detected.
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The aimof the studywas to determinewhether green tea catechins
and metabolites could be identiﬁed in human skin samples (blister
ﬂuid and biopsies), whether the bioavailability in skin could be related
to their presence in plasma andwhether the amountswere affected by
UVR exposure. In total, there were 15 metabolites identiﬁed after
3 months supplementation in at least two of the three samples
(plasma, blister ﬂuid and biopsies) obtained 3 h post green tea
supplement consumption, with only O-methyl-gallic acid-O-sulfate
and M6/M6′-O-sulfate identiﬁed in all three samples. In accordance
with other green tea bioavailability studies, there was a large
interindividual variation [36,37].
The blister ﬂuid is a vacuum-pressure-induced collection of the
extracellular ﬂuid surrounding cells and may contain a contribution
fromplasma. As expected, themajority of themetabolites identiﬁed in
more than one tissue sample were present within blister ﬂuid and
plasma, with limited metabolites identiﬁed in biopsy samples. It is
possible that the metabolites did not enter the skin cells, that the
metabolites present within the skin biopsy samples were bound to
intracellular proteins or that they were further metabolized. A
signiﬁcant ﬁnding of the study was the increase in O-methyl-M4-O-
sulfate observed in the postsupplementation UVR blister ﬂuid sample
compared to no UVR, and this difference may be an increase in
response to the external stress.M4 is a hydroxyl-phenyl-valerolactone
that derives frommicrobial metabolism of EGC [38] and, as suggested
in our previous study, is a biomarker of green tea consumption [31].
M6 (derived from EC consumption) was identiﬁed in all biopsy
samples (presupplementation and postsupplementation) for one
volunteer; however, this was possibly due to dietary consumption of
chocolate, black tea or wine and good dietary sources of EC, on the
previous day. As a 24-h dietary recall was not undertaken, the other
dietary sources of EC were not recorded.
After 3 months daily consumption, the metabolites quantiﬁed in
the plasma were in line with other studies [25,27–29]. The Cmax of
EGCGwas 45 nmol/Lwhen normalized to a 50 mg dose of EGCG in the
green tea supplements, which is also in line with previous studies of
plasma (reviewed by Williamson et al. [39]). For the ﬁrst time,
quercetin-O-sulfate, kaempferol-O-glucuronide, syringic acid-O-
sulfate, 3-hydroxybenzoic acid-O-sulfate and benzoic acid-O-sulfate
were identiﬁed in plasma samples post green tea consumption. The
identiﬁcation of quercetin and kaempferol after consumption of green
tea has been assessed previously in plasma, but only as aglycones post
enzyme deconjugation [40,41].
Our preliminary study [31] identiﬁed 8 metabolites in the skin
biopsy samples. Contrasting with the current work, the free-form
(unconjugated) derivatives of the metabolites present following
consumption of green tea supplements were only assessed after
enzyme deconjugation, and the tissue examined was limited to the
dermal layer of the skin. Only one catechin was identiﬁed in a biopsy
for the current study, whereas EC, EGC, 4′-O-methyl-EGC and EGCG
were tentatively identiﬁed in the pilot study. This is possibly due to the
accumulation of free-form derivatives following enzyme deconjuga-
tion, which may result in a higher LC-MS/MS response in comparison
to the lower concentrations of the individual conjugates for one
particular catechin. However, the current methodology gives a clearer
and more realistic overview of both the free-form and conjugatedFig. 2. Identiﬁcation of green tea catechinmetabolites for the individual subjects in plasma, blist
As peak areas for the conjugated green teametabolites in the plasmawere larger, plasma is pres
area ×10−7 (relative to the internal standard, 2 μg/ml EG). Hippuric acid is presented as micro
identiﬁed in subjects for more than one biological sample that are displayed are EC-O-sulfate, O
sulfate, M6/M6′-O-sulfate and hippuric acid. EC-O-glucuronide, O-Me-M4-O-sulfate, M4-O-glu
than one biological sample. EGCG and 3-hydroxybenzoic acid sulfate were identiﬁed in more t
sulfate andM6/M6′-O-sulfate graphs showbiopsy data. EC, epicatechin; EG, ethyl gallate; EGC, e
methyl; V, volunteer number.derivatives of the green tea catechin metabolites identiﬁed, even
though someof the individualmetabolitesmay consequently be under
the limit of detection.
This is theﬁrst bioavailability study to identify the presence of both
free and conjugated forms of green tea catechins and metabolites in
skin tissue, blister ﬂuid and plasma. The method reported good
recoveries for the majority of the compounds assessed. The main
limitation of the study is the lack of commercially available green tea
catechin and metabolite conjugated standards, and therefore, the
results obtained are speculative. Other analytical methods, such as
NMR, could be used to improve the identiﬁcation of the metabolites
within the samples. Overestimation may occur as the conjugated
forms ionize more efﬁciently and the precise response factors are also
unknown; therefore, the green tea catechins were reported relative to
standards and the conjugated forms were reported as peak areas
relative to the internal standard to improve the quality of the data.
In summary, the results of the study suggest that green tea catechin
metabolites can reach the skin postsupplementation in the unconju-
gated (free) form and as conjugated derivatives, as assessed using a
dual combination method to identify both [32], with an increase in O-
methyl-M4-O-sulfate following UVR exposure in blister ﬂuid. As
expected, the majority of metabolites were present in the conjugated
form. There was a clear overlap between the metabolites present in
the plasma samples collected 3 h postconsumption and the blister
ﬂuid. Therefore, any lowering of UVR-induced inﬂammatory markers
or improvement to skin health reported in future studies following
long-term green tea supplementation could potentially be associated
with the metabolites reported in the present study.Acknowledgments
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